Clinical Trials Logo

Filter by:
NCT ID: NCT02432924 Completed - Clinical trials for Cardiovascular Diseases

Using Combined Instantaneous and Multidimensional Feedback to Support a Change in Physical Activity Behaviour

Start date: October 2014
Phase: N/A
Study type: Interventional

The primary aim of the study is to examine whether the provision of personalised multidimensional physical activity profiles (derived from technological advances in physical activity monitoring) is supported by instantaneous physical activity feedback in fostering a meaningful change in physical activity behaviour amongst adults.

NCT ID: NCT02432846 Completed - Clinical trials for Renal Cell Carcinoma, Metastatic

Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)

MERECA
Start date: April 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare tumor response, progression free survival (PFS) and overall survival (OS) in newly diagnosed mRCC patients treated with Intuvax (INN: ilixadencel) pre-nephrectomy followed by Sunitinib post-nephrectomy vs Sunitinib post-nephrectomy patients.

NCT ID: NCT02432729 Completed - Cigarette Smoking Clinical Trials

A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation

RIBESC
Start date: May 5, 2015
Phase:
Study type: Observational

The purpose of this study was to understand the biological and functional changes after one year of smoking cessation and to collect data on a broad range of biomarkers of exposure (BoExp) and biomarkers of effect (BoE).

NCT ID: NCT02432313 Completed - Clinical trials for Pharmacokinetics of Anatabine

Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations

Start date: January 2015
Phase: Phase 1
Study type: Interventional

Parts 1 and 2: Subjects take 1 dose of various formulations of the study product, and provide samples for pharmacokinetic (PK) analysis after each, with at least 7 days between doses. Part 3: Subjects take 2-4 doses of study product or placebo for 6 days, plus 1 additional dose, and provides samples for PK analysis.

NCT ID: NCT02432274 Completed - Osteosarcoma Clinical Trials

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Start date: December 29, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study evaluating safety, tolerability, and efficacy of lenvatinib as single-agent, and in combination with chemotherapy (ifosfamide and etoposide) in children and adolescents with refractory or relapsed solid malignancies including differentiated thyroid carcinoma (single agent lenvatinib) and osteosarcoma (single agent and combination lenvatinib).

NCT ID: NCT02432235 Completed - Hodgkin Lymphoma Clinical Trials

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Start date: October 5, 2015
Phase: Phase 1
Study type: Interventional

This study evaluates camidanlumab tesirine in participants with relapsed/refractory Non-Hodgkin or Hodgkin lymphoma.

NCT ID: NCT02431988 Completed - Clinical trials for Diffuse Large B-Cell Lymphoma

Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation

COBALT
Start date: June 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to administer novel cluster of differentiation antigen 19 (CD19) specific Chimeric Antigen Receptor T-cells (CAR19 T-cells) to patients with relapsed or resistant Diffuse Large B Cell Lymphoma (DLBCL) to assess the safety and efficacy of this strategy as a bridge to allogeneic transplantation.

NCT ID: NCT02431780 Completed - Epilepsy Clinical Trials

A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection

ANSeR
Start date: February 12, 2015
Phase: N/A
Study type: Interventional

The ANSeR Clinical Investigation is a multi-centre, randomised, controlled, clinical investigation of a standalone decision support Algorithm for Neonatal Seizure Recognition, the ANSER Software system.

NCT ID: NCT02431624 Completed - Pain Clinical Trials

An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion

Start date: March 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the adhesion of BTDS patch 40 µg/h.

NCT ID: NCT02431247 Completed - Clinical trials for Immunodeficiency Virus Type 1, Human

A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Start date: July 6, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority in efficacy of a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed dose combination (FDC) tablet versus Darunavir/Cobicistat (DRV/COBI) FDC coadministered with Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) FDC in human immunodeficiency virus-1 (HIV-1) infected, antiretroviral (ARV) treatment naive adult participants.